Bullish on Pharma stocks: Sudip Bandyopadhyay, Destimoney Securities

In a chat with ET Now, Sudip Bandyopadhyay, MD & CEO, Destimoney Securities Pvt. Ltd., gives his hedging strategy


What would be your hedging strategy in this market?

We have been doing couple of things for sometime consistently. Though the valuations were looking attractive in many sectors including the rate sensitives, we have been sticking to the FMCG and pharma pack. We still believe that even in current market there is significant value buying opportunity in both FMCG and pharma. I will recommend my investors to continue investing in good quality FMCG and pharma stocks even in this kind of a market.